Pharmaceutical compositions

Details Pharmaceutical compositions Pharmaceutical compositions

1993-06-25

1995-08-22

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

424489, 424434, A61K 900

Patent

active

054438330

ABSTRACT:
A method of treatment of a condition selected from the group comprising conjunctivitis, keratitis, `allergic eyes`, adenovirus infections, corneal homograft rejection, anterior uveitis, nasal polyps, vasomotor rhinitis, allergic manifestations of the nasopharynx, reversible obstructive airways disease, Crohn's disease, distal colitis and proctitis, which method comprises administration to a patient suffering from such a condition of a therapeutically effective amount of an aqueous solution containing, as active ingredient, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dica rboxylic acid or a pharmaceutically acceptable salt thereof. Also described are novel pharmaceutical compositions suitable for use in such methods of treatment.

REFERENCES:
patent: 4328341 (1982-05-01), Raphael
patent: 4419352 (1983-12-01), Cox
patent: 4474787 (1984-10-01), Cairns
patent: 4698345 (1987-10-01), Dicker
patent: 4760072 (1988-07-01), Brown
patent: 4849427 (1989-07-01), Nassim
patent: 4866072 (1989-09-01), Edwards
patent: 4868192 (1989-09-01), Totton
Patel, K. R. "Dose-Response Study of Sodium Cromoglycate in Exercise-Induced Asthma," Thorax, vol. 37, pp. 663-666.
Br. J. Clin. Pharmac., vol. 24, Oct. 1987, pp. 493-501, "The Pharmacokinetics of Nedocromil Sodium, a New Drug for the Treatment of Reversible Obstructive Airways Disease, in Human Volunteers and Patients With Reversible Obstructive Airways Disease".
J. Med. Chem., vol. 28, No. 12, 1985, pp. 1832-1842, American Chemical Society, H. Cairns et al., "New Antiallergic Pyrano(3,2-g)quinoline-2,8-dicarboxylic Acids with Potential for the Topical Treatment of Asthma".
P. H. List: "Arzneiformenlehre" Chapter Konservierungmittel pp. 369-373, 1976.
P. H. List: "Arzneiformenlehre" Chapter Augenarzneien pp. 400-410, 1976.
R. Voigt: "Lehrbuch der pharmazeutischen Technologie", Chapter 27 Augentropfen, pp. 459-467, 1975.
Eur. J. Respir. Dis. (Suppl. 147) 1986, pp. 120-131, R. M. Auty: "The clinical development of a new agent for the treatment of airway inflammation, nedocromil sodium (Tilade)".
J. Allergy Clin. Immunol. vol. 79, No. 1, Feb. 19-25, 1987, p. 186, abstract 247. Schwartz et al. "Efficacy of hedocromil sodium . . . ragweed seasonal allergic rhimitis (SAR)".
J. Allergy Clin. Immuno. vol. 80, No. 2, Aug. 1987, pp. 218-222, Corrado et al. "The effect of nedocromil sodium on nasal provocation with allergen".
J. Allergy Clin. Immunol., vol. 81, No. 3, Mar. 1988, pp. 570-574 Ruhno et al. "Intranasal nedocromil sodium in the treatment of ragweed-allergic rhinitis".
Invest. Ophtalmol. Visual Sci., vol. 29, May 1-6, 1988, p. 229, Stockwell et al. "Dougle blind group comparative trial of 2% nedocromil . . . seasonal allergic conjunctivitis".
Pharmazie, vol. 37, No. 4, 1982, pp. 261-263 Pohloudek-Fabini et al. "Zur Stabilitat der Phenylquecksilbersalze".
Journal of Pharmaceutical Sciences, vol. 65, No. 4, Apr. 1976, pp. 628-630, Grady et al. "Testing of heat sealing by thermal analysis".
R. Voight, "Lehrbuch der pharmazeutischen Technologie," 5th edition, 1984, pp. 554-557, Verlag Chemie, Weinheim, DE.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2140362